TET1 and endometrial cancer: The levels of TET1 and TET2 (but not TET3) have been shown to be reduced in endometrial cancer as compared to matching normal [216], and reduced levels of TET1/2 correlate with reduced levels of 5-hmC and increased tumor aggressiveness (Figure 6b).